FAIRFAX GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P83001 | MANCHESTER, M25 1BT
Showing results 51-100 of 614
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ibuprofen | 865 | 96.8K | £2.1K | +70.1% ▲ |
| Lactulose | 836 | 503.1K | £4.7K | +153.9% ▲ |
| Allopurinol | 826 | 52.0K | £1.1K | -19.9% ▼ |
| Rosuvastatin calcium | 804 | 40.9K | £1.8K | -10.4% ▼ |
| Dapagliflozin | 801 | 33.3K | £41.4K | -36.0% ▼ |
| Lisinopril | 788 | 41.2K | £899 | -28.1% ▼ |
| Alendronic acid | 788 | 4,696 | £1.2K | +5.0% ▲ |
| Promethazine hydrochloride | 787 | 76.3K | £6.2K | +120.2% ▲ |
| Ferrous sulfate | 776 | 52.6K | £2.3K | +50.9% ▲ |
| Nitrofurantoin | 712 | 10.6K | £4.2K | +49.2% ▲ |
| Glucose blood testing reagents | 710 | 63.1K | £10.7K | -10.0% ▼ |
| Empagliflozin | 698 | 33.0K | £40.9K | +11.5% ▲ |
| Quetiapine | 695 | 32.4K | £10.8K | +11.6% ▲ |
| Montelukast | 690 | 29.5K | £1.5K | +0.8% vs avg |
| 676 | 383.0K | £5.3K | +156.2% ▲ | |
| Hydroxocobalamin | 666 | 971 | £2.2K | +38.4% ▲ |
| Progesterone | 656 | 53.2K | £10.9K | +56.7% ▲ |
| Betamethasone valerate | 649 | 59.3K | £2.9K | +68.6% ▲ |
| Alginic acid compound preparations | 646 | 289.3K | £4.2K | +10.3% ▲ |
| Pravastatin sodium | 646 | 30.9K | £1.4K | +98.9% ▲ |
| Lamotrigine | 645 | 45.8K | £6.8K | +9.2% ▲ |
| 643 | 81.9K | £3.8K | +35.5% ▲ | |
| Finasteride | 636 | 27.5K | £967 | -2.9% ▼ |
| 636 | 1,686 | £57.7K | +16.7% ▲ | |
| Ferrous fumarate | 618 | 46.0K | £1.7K | -14.7% ▼ |
| Flucloxacillin sodium | 602 | 25.4K | £1.3K | +33.9% ▲ |
| Fluticasone propionate (Inhalation) | 578 | 742 | £16.0K | +49.4% ▲ |
| Sildenafil (Erectile Dysfunction) | 576 | 4,264 | £590 | +14.3% ▲ |
| Latanoprost | 572 | 8,453 | £3.4K | +17.8% ▲ |
| Senna | 559 | 32.9K | £699 | -7.1% ▼ |
| Combined ethinylestradiol 30mcg | 544 | 39.3K | £2.4K | +95.9% ▲ |
| Cyanocobalamin | 544 | 33.8K | £4.4K | +54.1% ▲ |
| Famotidine | 539 | 27.0K | £15.9K | +10.5% ▲ |
| Estradiol with progestogen | 537 | 17.9K | £18.6K | +57.6% ▲ |
| Doxycycline hyclate | 532 | 6,340 | £609 | +3.8% ▲ |
| 526 | 578 | £3.5K | +122.7% ▲ | |
| Insulin aspart | 510 | 3,125 | £23.4K | +33.9% ▲ |
| Budesonide | 509 | 966 | £15.3K | -6.1% ▼ |
| Sumatriptan succinate | 506 | 4,943 | £2.6K | +42.9% ▲ |
| Methylphenidate hydrochloride | 496 | 17.5K | £17.9K | +92.1% ▲ |
| Atenolol | 494 | 25.4K | £558 | -18.1% ▼ |
| Gliclazide | 489 | 32.9K | £2.1K | -42.5% ▼ |
| Warfarin sodium | 469 | 29.3K | £988 | -0.5% vs avg |
| Thiamine hydrochloride | 461 | 45.4K | £1.4K | -12.5% ▼ |
| Buprenorphine | 460 | 3,105 | £7.6K | +25.6% ▲ |
| Spironolactone | 455 | 17.4K | £2.3K | -15.6% ▼ |
| Mirabegron | 450 | 17.1K | £15.7K | +12.0% ▲ |
| Cetirizine hydrochloride | 447 | 38.6K | £2.2K | -10.5% ▼ |
| Carbocisteine | 441 | 77.4K | £2.4K | -17.4% ▼ |
| Tiotropium bromide | 440 | 3,253 | £12.5K | +44.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.